Innovation Files Blog

Chinese firms with ties to Beijing—and in some cases China’s military—are quietly exploiting America’s open economy, taxpayer support, and weak post-acquisition oversight, and Congress should close those loopholes before more U.S. innovation and industrial capacity are used to advance China’s strategic aims.

The U.S. government needs to do what many nations around the world are already doing by leaning into rail technologies such as positive track control and automated track inspection, not resisting them on behalf of special interests.

Over the past 26 years, researchers on the International Space Station have produced roughly 4,000 research papers and have helped to develop treatments for several diseases, including cancer, Alzheimer’s, and heart disease.

As of 2022, China is producing over 35 percent of the publications in top-tier journals, up from nearly zero in 1980. At the same time, the United States has seen its share fall rapidly to about 25 percent.

The Consumer Product Safety Commission should shift more enforcement focus toward Chinese e-commerce platforms—like Temu and SHEIN—because, despite widespread safety violations linked to Chinese-made goods, these high-scale marketplaces face disproportionately little scrutiny despite posing significant risks to U.S. consumers.

Virginia’s one-hour social media limit for minors is a misguided policy that undermines parental authority, raises constitutional concerns, and fails to effectively address the real drivers of youth online harm.

“Emergency” legislation like the Sanders-Ocasio-Cortez AI Data Center Moratorium Act is not necessary to protect Americans from rate increases. Concerns about energy and data centers are misplaced, and there are plenty of options to ensure a smooth path to growth.

Sales of Chinese hybrids and plug-in hybrids in Europe increased by a factor of 14 between August 2024 and August 2025

The Trump administration’s Section 232 pharmaceutical tariffs will needlessly raise drug costs, harm U.S. patients, and undermine both domestic manufacturing and global biopharmaceutical innovation, while better policy options exist to strengthen the industry without these damaging side effects.

Cyberattacks on critical infrastructure—particularly health care—are escalating, and Congress should pass the Health Care Cybersecurity and Resiliency Act and expand similar sector-specific cybersecurity programs across all critical infrastructure sectors to provide tailored funding, guidance, and support.